Daily News Podcast

Bempedoic acid: funny name, serious LDL lowering

Publish date: March 15, 2019

 

Bempedoic acid safely dropped LDL cholesterol, and now it’s up for FDA approval. Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Trump targets abortion by denying family planning funds
MDedge Psychiatry
Online vitriol’s expansion into doctor discussion sites
MDedge Psychiatry
Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge Psychiatry
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Psychiatry
Achieving recovery not a one-size-fits-all proposition
MDedge Psychiatry
Esketamine gets the green light for depression
MDedge Psychiatry
Ready for universal hepatitis C testing?
MDedge Psychiatry
Autism risk with in utero infections
MDedge Psychiatry
Aspirin and lower risk of COPD flare-up
MDedge Psychiatry
Semaglutide plus SGLT2 inhibitors for type 2 diabetes
MDedge Psychiatry